ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1509

Associations between Perceived Stress and Joint Signs in an Anti-Cyclic Citrullinated Peptide Antibody Positive at-Risk Population

Kristen J. Polinski1, Elizabeth A. Bemis1, M. Kristen Demoruelle2, Marie L. Feser2, LauraKay Moss2, Jennifer Seifert2, V. Michael Holers3, Kevin D. Deane2 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Division of Rheumatology, University of Colorado Denver, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), Rheumatoid arthritis (RA) and stress

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestions, and Outcomes Poster – ARHP

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Psychosocial factors have been associated with rheumatoid arthritis (RA) outcomes, but have not been well characterized in the early development of RA. We examined the associations of perceived stress, measured by the Perceived Stress Scale-14 (PSS), with joint signs in an anti-cyclic citrullinated peptide (CCP) antibody positive population.

Methods: At community health fairs from 2014-2018, 56 subjects without previously diagnosed RA were found CCP positive through the CCP3 test (Inova). Subjects were recruited into a prospective cohort, and at their immediate post-health fair research visit (baseline) 14 had at least 1 tender joint, 7 had at least 1 swollen joint based on a rheumatologist exam, and 2 were classified as RA by 2010 ACR/EULAR Criteria only. The PSS responses were summed to obtain a total score, in which a higher score indicates greater perceived stress. Additionally, responses on the PSS underwent an explanatory factor analysis which suggested two meaningful factors: 1) perception of control, named ‘helplessness’ and 2) ability to cope with stress, named ‘self-efficacy.’ These factors align with other studies suggesting a two-factor structure for the PSS. T-tests and multivariable logistic regression assessed the associations of PSS-related scores with joint signs.

Results: Individuals with at least 1 tender joint compared to those without a tender joint have a higher total PSS score, higher helplessness or poor self-efficacy sub-scores (Table). A one point increase in the total PSS score was associated with a 12% increase in the odds of having a tender joint. Similarly, increases in the helplessness and self-efficacy sub-scores were associated with a 16% and 21% increase in the odds of tender joints, respectively. A sensitivity analysis removing the two individuals with newly classified RA at their baseline visit found that the absolute differences in the mean total PSS and self-efficacy scores remained, while ORs were slightly attenuated and not significant.

Conclusion: In a cohort of untreated CCP positive individuals, we found a significant association between higher perceived stress and joint tenderness. The ability to cope or control stressors may be an important component of the evolution from CCP positivity to joint signs that could indicate early inflammatory arthritis even if a swollen joint consistent with clear inflammatory arthritis is not seen. Further longitudinal study is needed to better understand the direction of the relationships between these factors, underlying immune dysregulation and transitions to classified RA. This is important because a relationship between perceived stress and clinical signs of disease in individuals at-risk for developing RA may support the incorporation of stress-targeted therapy management and other global health improvement activities, with the potential for increased quality of life.

 

Table 1. Associations between PSS-related scores and Joint Signs

 

At least 1 Tender Joint Sign (N=14)

No Tender Joint Signs (N=42)

Odds Ratio (95% CI)

Total PSS score, mean (SD)*

25.8 (6.8)

19.1 (9.2)

1.12 (1.02, 1.23)

PSS Helplessness score, mean (SD)*

14.1 (5.6)

10.1 (5.7)

1.16 (1.02, 1.32)

PSS Self-efficacy score, mean (SD)*

10.0 (3.7)

6.7 (4.6)

1.21 (1.01, 1.45)

 

At least 1 Swollen Joint Sign  (N=7)

At least 1 Swollen Joint Sign (N=49)

Odds Ratio (95% CI)

Total PSS score, mean (SD)

27.1 (7.8)

19.8 (9.0)

1.11 (0.95, 1.32)

PSS Helplessness score, mean (SD)

14.1 (5.6)

10.1 (5.7)

1.11 (0.98, 1.25)

PSS Self-efficacy score, mean (SD)*

11.3 (3.7)

7.0 (4.5)

1.28 (0.99, 1.67)

* indicates T-test p-value of <0.05 for comparison of mean PSS-related scores

Abbreviations: standard deviation (SD); odds ratio (OR); confidence interval (CI).

Odds ratios obtained from logistic regression models adjusted for age, race, and ever smoking status. The joints assessed on the examination include the elbow, wrist, metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal.

 


Disclosure: K. J. Polinski, None; E. A. Bemis, None; M. K. Demoruelle, None; M. L. Feser, None; L. Moss, None; J. Seifert, None; V. M. Holers, None; K. D. Deane, Janssen, 2; J. M. Norris, None.

To cite this abstract in AMA style:

Polinski KJ, Bemis EA, Demoruelle MK, Feser ML, Moss L, Seifert J, Holers VM, Deane KD, Norris JM. Associations between Perceived Stress and Joint Signs in an Anti-Cyclic Citrullinated Peptide Antibody Positive at-Risk Population [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/associations-between-perceived-stress-and-joint-signs-in-an-anti-cyclic-citrullinated-peptide-antibody-positive-at-risk-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-between-perceived-stress-and-joint-signs-in-an-anti-cyclic-citrullinated-peptide-antibody-positive-at-risk-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology